Items in AFP with MESH term: Asthma
Should Salmeterol Be Used for Long-Term Asthma Control? - Cochrane for Clinicians
ABSTRACT: The National Asthma Education and Prevention Program recently updated its guidelines for the management of asthma. An evidence-based approach was used to examine several key issues regarding appropriate medical therapy for patients with asthma. The updated guidelines have clarified these issues and should alter the way physicians prescribe asthma medications. Chronic inhaled corticosteroid use is safe in adults and children, and inhaled corticosteroids are recommended as first-line therapy in adults and children with persistent asthma, even if the disease is mild. Other medications, such as cromolyn, theophylline, and leukotriene modifiers, now are considered alternative treatments and should have a more limited role in the management of persistent asthma. The addition of a long-acting beta2 agonist to an inhaled corticosteroid is superior to all other combinations as well as to higher dosages of inhaled corticosteroids alone. Combination therapy with an inhaled corticosteroid and a long-acting beta2 agonist is the preferred treatment for adults and children with moderate to severe asthma. Antibiotic therapy offers no additional benefit in patients with asthma exacerbations.
Are Metered-Dose Inhalers with Holding Chambers Better Than Nebulizers for Treating Acute Asthma? - Cochrane for Clinicians
NAEPP Updates Guidelines for the Diagnosis and Management of Asthma - Practice Guidelines
Long-Acting Beta2 Agonists as Steroid-Sparing Agents - Cochrane for Clinicians
Beta2 Agonists in the Treatment of Asthma - Editorials
Putting Clinical Guidelines Into Practice - Improving Patient Care